356
Participants
Start Date
July 19, 2017
Primary Completion Date
September 19, 2018
Study Completion Date
September 19, 2018
Fezolinetant
Oral Capsule
Placebo
Oral Capsule
Research Site, New York
Research Site, Williamsville
Research Site, Philadelphia
Research Site, Elkridge
Research Site, Vienna
Research Site, Charlottesville
Research Site, Mt. Pleasant
Research Site, Norcross
Research Site, Atlanta
Research Site, Ormond Beach
Research Site, DeLand
Research Site, Miami
Research Site, Jupiter
Research Site, Lake Worth
Research Site, Crystal River
Research Site, Port Saint Lucie
Research Site, Birmingham
Research Site, Anniston
Research Site, Clarksville
Research Site, Kingsport
Research Site, Columbus
Research Site, Columbus
Research Site, Cleveland
Research Site, Cincinnati
Research Site, Champaign
Research Site, Lincoln
Research Site, Norfolk
Research Site, Marrero
Research Site, Oklahoma City
Research Site, Plano
Research Site, Hurst
Research Site, Lampasas
Research Site, Houston
Research Site, San Antonio
Research Site, Denver
Research Site, Meridian
Research Site, Riverton
Research Site, Phoenix
Research Site, Las Vegas
Research Site, Los Angeles
Research Site, Thousand Oaks
Research Site, Panorama City
Research Site, Valley Village
Research Site, Oceanside
Research Site, San Diego
Research Site 052, Sacramento
Research Site 058, Sacramento
Research Site, Seattle
Research Site, Spokane
Research Site, Milford
Research Site, Watertown
Astellas Pharma Global Development, Inc.
INDUSTRY